Product Details

Apidra 100 IU/mL Solution for Injection in a Vial**

Insulin glulisine
1000 units/10 mL
Solution for injection

ROA

Subcutaneous

Applicant Name

Sanofi-Aventis Nigeria Limited

NRN

A6-0366

Status

Active


Composition

Apidra 100 Units/ml solution for injection in a vial. Each vial contains 10 mL of solution for injection, equivalent to 1000 Units. Each mL contains 100 Units insulin glulisine* (equivalent to 3.49 mg) *Insulin glulisine is produced by recombinant DNA technology in Escherichia coli  

ATC Code

A10AB06  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 x 10 mL  

Product Description

Solution for injection in a vial. Clear, colourless, aqueous solution

Manufacturer Name

Sanofi-Aventis Deutschland GmbH

Manufacturer Country

GERMANY  

Approval Date

2022-12-18  

Expiry Date

2027-12-17